Antimicrobial Resistance in the Intensive Care Unit: A Focus on Gram-Negative Bacterial Infections

Journal of Intensive Care Medicine
Shawn H MacVane

Abstract

Bacterial infections are a frequent cause of hospitalization, and nosocomial infections are an increasingly common condition, particularly within the acute/critical care setting. Infection control practices and new antimicrobial development have primarily focused on gram-positive bacteria; however, in recent years, the incidence of infections caused by gram-negative bacteria has risen considerably in intensive care units. Infections caused by multidrug-resistant (MDR) gram-negative organisms are associated with high morbidity and mortality, with significant direct and indirect costs resulting from prolonged hospitalizations due to antibiotic treatment failures. Of particular concern is the increasing prevalence of antimicrobial resistance to β-lactam antibiotics (including carbapenems) among Pseudomonas aeruginosa and Acinetobacter baumannii and, recently, among pathogens of the Enterobacteriaceae family. Treatment options for infections caused by these pathogens are limited. Antimicrobial stewardship programs focus on optimizing the appropriate use of currently available antimicrobial agents with the goals of improving outcomes for patients with infections caused by MDR gram-negative organisms, slowing the progression of antim...Continue Reading

References

May 16, 1980·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·R P Ambler
Jun 1, 1995·Antimicrobial Agents and Chemotherapy·K BushA A Medeiros
Jul 1, 1997·The American Journal of Medicine·J D PitoutW E Sanders
May 21, 1999·Archives of Internal Medicine·Y CarmeliM H Samore
Sep 1, 2000·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·M J RichardsR P Gaynes
Mar 22, 2002·Intensive Care Medicine·Corinne AlbertiRoger Le Gall
Jun 19, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David L PatersonVictor L Yu
Jun 18, 2005·Joint Commission Journal on Quality and Patient Safety·Roger ResarThomas Nolan
Dec 16, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sara E Cosgrove
Jan 31, 2006·American Journal of Infection Control·Nefise OztoprakHurrem Bodur
Jun 28, 2006·Archives of Internal Medicine·Svenja J AlbrechtEbbing Lautenbach
Dec 19, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Timothy H DellitUNKNOWN Society for Healthcare Epidemiology of America
Dec 29, 2006·The New England Journal of Medicine·Peter PronovostChristine Goeschel
Dec 6, 2007·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Ebbing Lautenbach, Ron E Polk
Oct 14, 2008·Expert Review of Anti-infective Therapy·Lisa L MaragakisSara E Cosgrove
Oct 25, 2008·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Alicia I HidronUNKNOWN Participating National Healthcare Safety Network Facilities
Sep 23, 2009·Joint Commission Journal on Quality and Patient Safety·Sanjay SaintSarah L Krein
Dec 3, 2009·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Ebbing LautenbachMyoung Kim
Dec 3, 2009·JAMA : the Journal of the American Medical Association·Jean-Louis VincentUNKNOWN EPIC II Group of Investigators
Mar 26, 2010·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Emily K ShumanCarol E Chenoweth
Aug 5, 2010·Critical Care Medicine·Emily K Shuman, Carol E Chenoweth
Apr 5, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Naomi P O'GradyUNKNOWN Healthcare Infection Control Practices Advisory Committee (HICPAC)
Sep 9, 2011·Current Opinion in Critical Care·Kavitha Prabaker, Robert A Weinstein
Sep 13, 2011·Annals of Intensive Care·Argyris S Michalopoulos, Matthew E Falagas
Sep 23, 2011·American Journal of Infection Control·Carlos A DiazGranados
Mar 16, 2012·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Marion ElligsenNick Daneman
Mar 16, 2012·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·G Jonathan LewisPaul P Cook
Mar 27, 2012·The Journal of Surgical Research·Shiva Sarraf-YazdiSteven N Vaslef
Nov 7, 2012·Critical Care : the Official Journal of the Critical Care Forum·Christina M KatsiosAndrew M Morris
Nov 23, 2012·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·P ZarbUNKNOWN Hospital Contact Points for the ECDC pilot point prevalence survey
Dec 12, 2012·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Dawn M SievertUNKNOWN National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities

❮ Previous
Next ❯

Citations

Jul 28, 2017·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Pin LiuJingfu Qiu
Mar 29, 2018·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Ahmed El-NawawyMarwa M R El-Alfy
Jul 12, 2018·Minerva anestesiologica·Giorgia MontrucchioLuca Brazzi
Sep 22, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Scott R EvansUNKNOWN Antibacterial Resistance Leadership Group (ARLG)
Aug 28, 2017·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Jason MunguiaVictor Nizet
Jun 25, 2020·Biomaterials Science·Chaofeng WangShuilin Wu
Jan 10, 2017·Frontiers in Microbiology·Piotr MajewskiElżbieta Tryniszewska
Aug 12, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Katrin RichterVeronika Grau
Sep 14, 2018·Microbiology and Molecular Biology Reviews : MMBR·Carlos JuanAntonio Oliver
Apr 21, 2020·World Journal of Emergency Surgery : WJES·Massimo SartelliFausto Catena
Sep 12, 2017·Expert Review of Respiratory Medicine·Katherine L RobertsMarin H Kollef
Jul 30, 2020·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Tao ChenTieli Zhou
Mar 29, 2019·Antimicrobial Agents and Chemotherapy·Ronald DomalaonFrank Schweizer
Aug 3, 2019·Critical Care Nurse·May Mei-Sheng Riley
Nov 11, 2019·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Jordi RelloUNKNOWN Nine-I study Group
Apr 11, 2019·European Journal of Microbiology & Immunology·Katharina MrazekMarkus M Heimesaat
Nov 27, 2020·Frontiers in Microbiology·Soufiane TelhigSylvie Rebuffat
Dec 23, 2017·Deutsches Ärzteblatt International·Cornelius RemschmidtFrank Schwab
Mar 4, 2021·Burns and Trauma·Pengju ZhangCanhua Huang
Jun 7, 2017·Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine·Manoj Kumar SahuBalram Airan
Jun 17, 2021·Pharmacotherapy·Jamie L WagnerLauren R Biehle
Jul 13, 2021·Antimicrobial Agents and Chemotherapy·Justyna W AdamiakHelen I Zgurskaya

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.